politics

Iran war squeezes India's pharma supply chain

29 Nisan 2026DW

🤖AI Özeti

The ongoing conflict in Iran is causing significant disruptions in India's pharmaceutical supply chain. Increased energy and freight costs, along with a heavy reliance on Chinese active pharmaceutical ingredients (APIs), are putting pressure on profit margins. This situation raises concerns about potential drug price hikes and shortages in the near future.

💡AI Analizi

As the geopolitical landscape shifts due to the Iran war, India's pharmaceutical industry faces a critical juncture. The dependency on Chinese APIs not only exposes vulnerabilities in supply chains but also highlights the need for diversification. Policymakers and industry leaders must consider strategic shifts to mitigate risks and ensure the stability of drug availability and pricing.

📚Bağlam ve Tarihsel Perspektif

India is one of the largest producers of generic drugs globally, and any disruption in its supply chain can have far-reaching implications not only for domestic markets but also for global healthcare systems that rely on Indian pharmaceuticals.

This article reflects the situation as of October 2023 and may not account for subsequent developments.

Orijinal Kaynak

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Kaynağı Görüntüle

NewsAI Mobil Uygulamaları

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.

App Store'dan İndir Google Play'den İndir

Iran war squeezes India's pharma supply chain

🤖AI Özeti

💡AI Analizi

📚Bağlam ve Tarihsel Perspektif

Orijinal Kaynak

İlgili Haberler

Burnham Sees 'Challenging' UK Local Elections for Labour (Video)

IAEA Believes It Knows Where Iran's Buried Uranium Is

Israeli strike kills five family members in Lebanon

NewsAI Mobil Uygulamaları